ARROWHEAD PHARMACEUTICALS, INC. (ARWR) Operating margin 2016–2025
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) operating margin by fiscal year — reported operating income divided by reported revenue.
11.9%FY2025 · since FY2016: -51627.1% → 11.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 11.9% | +16938.9 pp |
| FY2024 | -16927.1% | -16841.9 pp |
| FY2023 | -85.2% | -11.8 pp |
| FY2022 | -73.4% | +34.4 pp |
| FY2021 | -107.8% | -1.9 pp |
| FY2020 | -105.9% | -142.1 pp |
| FY2019 | 36.3% | +382.8 pp |
| FY2018 | -346.5% | -228.7 pp |
| FY2017 | -117.8% | +51509.3 pp |
| FY2016 | -51627.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice